Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
The Significance of Membrane Transport01:44

The Significance of Membrane Transport

The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TRPV4: A Promising Therapeutic Target Ion Channel─Discovery of Ultrapotent Selective Antagonists.

Journal of medicinal chemistry·2026
Same author

Correction: Regioselective synthesis of aza-saccharins <i>via</i> anionic [1,4] Fries-type rearrangement of aryl sulfonimidoyl fluorides.

Chemical science·2026
Same author

A molecular stabiliser of an inhibitory eIF2B-eIF2(αP) complex activates the Integrated Stress Response.

Nature communications·2026
Same author

Regioselective synthesis of aza-saccharins <i>via</i> anionic [1,4] Fries-type rearrangement of aryl sulfonimidoyl fluorides.

Chemical science·2026
Same author

Selective oxidation by TS-1 coupled with in-situ synthesised H<sub>2</sub>O<sub>2</sub>.

Fundamental research·2026
Same author

Direct oxidative carbonylation of methane to acetic acid via high-valent iron-oxo mediated water activation.

Nature communications·2026

Related Experiment Video

Updated: Jun 18, 2026

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
07:56

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

Emerging structure-function relationships defining monoamine NSS transporter substrate and ligand affinity.

Ching-I Anderson Wang1, Richard J Lewis

  • 1Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane, Australia.

Biochemical Pharmacology
|December 4, 2009
PubMed
Summary

Monoamine transporters regulate neurotransmitter levels. Structure-function studies using homologous proteins like LeuT(Aa) are advancing understanding of these transporters for CNS therapeutics.

More Related Videos

Modeling Ligands into Maps Derived from Electron Cryomicroscopy
09:30

Modeling Ligands into Maps Derived from Electron Cryomicroscopy

Published on: July 19, 2024

High-Throughput Expression and Purification of Human Solute Carriers for Structural and Biochemical Studies
07:10

High-Throughput Expression and Purification of Human Solute Carriers for Structural and Biochemical Studies

Published on: September 29, 2023

Related Experiment Videos

Last Updated: Jun 18, 2026

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
07:56

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

Modeling Ligands into Maps Derived from Electron Cryomicroscopy
09:30

Modeling Ligands into Maps Derived from Electron Cryomicroscopy

Published on: July 19, 2024

High-Throughput Expression and Purification of Human Solute Carriers for Structural and Biochemical Studies
07:10

High-Throughput Expression and Purification of Human Solute Carriers for Structural and Biochemical Studies

Published on: September 29, 2023

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Monoamine transporters (neurotransmitter sodium symporter family) regulate synaptic neurotransmitter concentrations.
  • Serotonin, dopamine, and noradrenaline transporters are critical in addiction and CNS diseases.
  • Understanding their molecular mechanisms is key for developing targeted therapeutics.

Purpose of the Study:

  • To review structure-function relationships of monoamine transporters.
  • To elucidate molecular determinants of transporter-ligand interactions.
  • To discuss mechanisms of substrate binding, transport, and inhibition.

Main Methods:

  • Literature review of pharmacological, immunological, and biochemical studies.
  • Analysis of three-dimensional homology modeling, including crystal structures of homologous proteins (e.g., LeuT(Aa)).
  • Comparison of structure-function data across SLC6 NSS family transporters.

Main Results:

  • Crystal structures of LeuT(Aa) with amino acids and inhibitors provide insights into NSS transporter architecture.
  • Molecular interactions observed in LeuT(Aa) support previous mutational study predictions for monoamine transporters.
  • Homology models are enabling rational approaches to understand NSS transporter-ligand complexes.

Conclusions:

  • Recent structural data, particularly from LeuT(Aa), are crucial for understanding monoamine transporter function at a molecular level.
  • This knowledge facilitates the rational design of CNS therapeutics with improved specificity and affinity.
  • Further comparison with other SLC6 NSS transporters will refine our understanding of substrate transport and inhibition.